Daniel Sharp
Director/Board Member at ALCIDION GROUP LIMITED
Net worth: 531 764 $ as of 2024-03-30
Profile
Daniel Sharp is currently a Non-Executive Director at Botanix Pharmaceuticals Ltd.
and an Independent Non-Executive Director at Alcidion Group Ltd.
He previously served as an Independent Non-Executive Director at ImpediMed Ltd.
in 2023, an Executive Director at Shaw & Partners Corporate Finance Pty Ltd., and an Executive Director at Canaccord Genuity (Australia) Ltd.
from 2012 to 2020.
He also served as an Independent Non-Executive Director at Race Oncology Ltd.
in 2022-2023.
Mr. Sharp received his undergraduate and graduate degrees from Monash University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMPEDIMED LIMITED
0.41% | 2023-09-27 | 8,234,192 ( 0.41% ) | 494 216 $ | 2024-03-30 |
ALCIDION GROUP LIMITED
0.08% | 2023-06-29 | 1,128,572 ( 0.08% ) | 37 548 $ | 2024-03-30 |
Daniel Sharp active positions
| Companies | Position | Start |
|---|---|---|
| ALCIDION GROUP LIMITED | Director/Board Member | 2021-08-31 |
| BOTANIX PHARMACEUTICALS LIMITED | Director/Board Member | 2022-03-21 |
Former positions of Daniel Sharp
| Companies | Position | End |
|---|---|---|
| IMPEDIMED LIMITED | Director/Board Member | 2023-09-27 |
| RACE ONCOLOGY LIMITED | Director/Board Member | 2023-06-28 |
Canaccord Genuity (Australia) Ltd.
 Canaccord Genuity (Australia) Ltd. Investment Banks/BrokersFinance Canaccord Genuity (Australia) Ltd. (Canaccord Genuity Australia) is the Australian full service stockbroking and wealth management subsidiary of Canaccord Genuity Group Inc. (TSE: CF) in Canada. Headquartered in Melbourne, Canaccord Genuity Australia was founded by Anthony Murphy and provides wealth management services including portfolio management, portfolio administration and broking services to individual, institutional and corporate clients. | Director/Board Member | 2019-12-31 |
Shaw & Partners Corporate Finance Pty Ltd.
 Shaw & Partners Corporate Finance Pty Ltd. Investment Banks/BrokersFinance Part of EFG International AG, Shaw & Partners Corporate Finance Pty Ltd. is a brokerage firm founded in 1987. The private company is based in Sydney, Australia and provides brokerage services. | Corporate Officer/Principal | - |
Training of Daniel Sharp
| Monash University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
| IMPEDIMED LIMITED | Health Technology |
| ALCIDION GROUP LIMITED | Technology Services |
| RACE ONCOLOGY LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
Shaw & Partners Corporate Finance Pty Ltd.
Shaw & Partners Corporate Finance Pty Ltd. Investment Banks/BrokersFinance Part of EFG International AG, Shaw & Partners Corporate Finance Pty Ltd. is a brokerage firm founded in 1987. The private company is based in Sydney, Australia and provides brokerage services. | Finance |
Canaccord Genuity (Australia) Ltd.
Canaccord Genuity (Australia) Ltd. Investment Banks/BrokersFinance Canaccord Genuity (Australia) Ltd. (Canaccord Genuity Australia) is the Australian full service stockbroking and wealth management subsidiary of Canaccord Genuity Group Inc. (TSE: CF) in Canada. Headquartered in Melbourne, Canaccord Genuity Australia was founded by Anthony Murphy and provides wealth management services including portfolio management, portfolio administration and broking services to individual, institutional and corporate clients. | Finance |
- Stock Market
- Insiders
- Daniel Sharp
